Nuwellis, Inc. (NUWE)
- Previous Close
1.5900 - Open
1.3700 - Bid 1.4600 x 400
- Ask 1.5600 x 400
- Day's Range
1.3500 - 1.6800 - 52 Week Range
1.0000 - 43.7500 - Volume
688,535 - Avg. Volume
700,062 - Market Cap (intraday)
2.838M - Beta (5Y Monthly) 0.42
- PE Ratio (TTM)
-- - EPS (TTM)
-120.9600 - Earnings Date Nov 5, 2024 - Nov 11, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
16.00
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
www.nuwellis.comRecent News: NUWE
View MorePerformance Overview: NUWE
Trailing total returns as of 10/10/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NUWE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NUWE
View MoreValuation Measures
Market Cap
2.97M
Enterprise Value
2.60M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.03
Price/Book (mrq)
2.58
Enterprise Value/Revenue
0.29
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-232.24%
Return on Assets (ttm)
-79.49%
Return on Equity (ttm)
-987.45%
Revenue (ttm)
9.01M
Net Income Avi to Common (ttm)
-22.81M
Diluted EPS (ttm)
-120.9600
Balance Sheet and Cash Flow
Total Cash (mrq)
1.02M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-12.32M
Research Analysis: NUWE
View MoreCompany Insights: NUWE
NUWE does not have Company Insights